Legal Opinion
In Re Vioxx Class Cases
California Court of Appeal
Decided December 15, 2009No. B216521PublishedCited by 107 opinions
1Opinion of the Court
Opinion
CROSKEY, J.
Defendant Merck & Co., Inc. (Merck), manufactured and marketed Vioxx, a pain-relieving drug. Vioxx was pulled from the market on September 30, 2004, after a study indicated that the drug created a risk of adverse cardiovascular effects. The plaintiffs in this action brought suit against Merck. Plaintiffs do not assert that they suffered any adverse effects from taking Vioxx. Instead, they assert that, due to its cardiovascular risks, Vioxx was less safe than other, less expensive, pain relievers. Plaintiffs seek recovery, on behalf of all persons and entities in California…
2Cases cited17 opinions
- Bank of the West v. Superior CourtCalifornia Supreme Court · 1992
- Korea Supply Co. v. Lockheed Martin Corp.California Supreme Court · 2003
- In Re Tobacco II CasesCalifornia Supreme Court · 2009
- Cortez v. Purolator Air Filtration Products Co.California Supreme Court · 2000
- Lavie v. Procter & Gamble Co.California Court of Appeal · 2003
12 more not listed; retrieve them via the Exa API.
3Cited by107 opinions
- Stearns v. Ticketmaster Corp.Court of Appeals for the Ninth Circuit · 2011
- Klein v. Chevron U.S.A., Inc.California Court of Appeal · 2012
- Ries v. Arizona Beverages USA LLCDistrict Court, N.D. California · 2012
- Amanda Sateriale v. R J Reynolds Tobacco CompanyCourt of Appeals for the Ninth Circuit · 2012
- Benjamin Berger v. Home Depot U.S.A., Inc.Court of Appeals for the Ninth Circuit · 2014
102 more not listed; retrieve them via the Exa API.